Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
29
datasets available to search
ShareScore release 0.9.0
Dataset results
29 results for “Pentavalent”
Data from: Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study
Background: In Ethiopia, there are no studies on age-appropriate vaccinations that children received at the recommended specific ages. Therefore, we assessed age appropriate vaccination coverage and its associated factors among children 12 to 23 months of age in Menz Lalo district, northeast Ethiopia. Methods: A community based cross sectional study was conducted in Menz Lalo district from March to April, 2018 among 417 mothers/caregivers with children 12 to 23 months of age using simple random sampling technique. Data were collected using pretested structured Amharic questionnaire. Age appropriate vaccination coverage was measured using World Health Organization vaccination schedule recommendation. Information about children vaccination status was collected from children vaccination cards. Data was entered into Epi-Info7 software and exported to SPSS-20 for analysis. Logistic regression analysis was carried out to identify factors associated with age inappropriate vaccinations. A p-value of < 0.05 was considered to sate statistically significant association. Results: Age appropriate vaccination coverage were 39.1% (95% CI: 34.1-43.6) for Pentavalent 1, 36.3% (95% CI: 30.5-40) for Pentavalent 2, 30.3% (95% CI: 23.5-32.4) for Pentavalent 3 and 26.4% (95% CI: 18-29.4) for measles vaccine doses. Age inappropriate Pentavalent 1-3 vaccinations was associated with being male child (AOR: 0.47, 95% CI: 0.29-0.74), absence of telephone (AOR: 2.2, 95% CI: 1.4-3.6), absence of usual caretaker (AOR: 2.6, 95% CI: 1.3-5.2), unplanned pregnancy (AOR: 1.9, 95% CI: 1.1-3.5), missing antenatal conference participation (AOR: 2.7, 95% CI: 1.3-5.7), first birth order (AOR: 0.34, 95% CI: 0.17-0.68) and insufficient knowledge (AOR: 2.7, 95% CI: 1.6-4.4). Conclusion: The proportion of age appropriate vaccinations coverage was low in the study area. Modifiable factors were associated with age inappropriate vaccinations. Vaccination interventions should consider identified modifiable factors to improve age appropriate vaccinations coverage.
Pentavalent U reactivity impacts U isotopic fractionation during reduction by magnetite
<p>Original data pertaining to the manuscript 'Pentavalent U reactivity impacts U isotopic fractionation during reduction by magnetite' published in Environmental Science and Technology by Zezhen Pan, Luca Loreggian, Yvonne Roebbert, Barbora Bartova, Myrtille O.J.Y. Hunault, Stefan Weyer, Rizlan Bernier-Latmani.</p> <p><a href="https://doi.org/10.1021/acs.est.3c10324">https://doi.org/10.1021/acs.est.3c10324</a></p>
Persistence of the isotopic signature of pentavalent uranium in magnetite
<p>Original data pertaining to the manuscript 'Persistence of the isotopic signature of pentavalent uranium in magnetite' published in Environmental Science and Technology by Zezhen Pan, Yvonne Roebbert, Aaron Beck, Barbora Bartova, Tonya Vitova, Stefan Weyer, Rizlan Bernier-Latmani.</p> <p><a href="https://doi.org/10.1021/acs.est.1c06865">https://doi.org/10.1021/acs.est.1c06865</a></p>
Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination
ClinicalTrials.gov study NCT01357720. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid
ClinicalTrials.gov study NCT01701999. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.
ClinicalTrials.gov study NCT03135834. IPD Sharing: YES. Countries: 4. Publications: 2.
Data from: Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study
Open the record for dataset details and reuse information.
Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age
ClinicalTrials.gov study NCT01470287. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)
ClinicalTrials.gov study NCT03964012. IPD Sharing: UNDECIDED. Countries: 2. Publications: 4.
Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old
ClinicalTrials.gov study NCT05739292. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
ClinicalTrials.gov study NCT00317980. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger
ClinicalTrials.gov study NCT02145000. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
ClinicalTrials.gov study NCT03474055. IPD Sharing: NO. Countries: 1. Publications: 1.
An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)
ClinicalTrials.gov study NCT01960725. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents
ClinicalTrials.gov study NCT06128733. IPD Sharing: YES. Countries: 2. Publications: 0.
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
ClinicalTrials.gov study NCT06647407. IPD Sharing: YES. Countries: 9. Publications: 0.
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
ClinicalTrials.gov study NCT06605755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
ClinicalTrials.gov study NCT05032391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pentavalent DTaP-Hep B-IPV
ClinicalTrials.gov study NCT00133445. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
ClinicalTrials.gov study NCT00818818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.